JOHNSON JOHN
SEC CIK 1410781 · EDGAR
BoughtSold
Most active insiders at AXGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Began Marc A | EVP, GC | — | $3.88M |
| 2 | Burke William P. Mr. | Dir | — | $2.82M |
| 3 | Weiler Kathy Johnson | Dir | — | $2.74M |
| 4 | DALE MICHAEL D | CEO | — | $2.67M |
| 5 | Wendell Amy McBride | Dir | — | $2.00M |
| 6 | JOHNSON JOHN | Dir | — | $1.87M |
| 7 | TYNDALL JOSEPH A. | Dir | — | $951.8K |
| 8 | Hartley Lindsey Marie | CFO | — | $942.2K |
| 9 | DeVinney Erick Wayne | Chief Innovation Off | — | $780.6K |
| 10 | THOMAS PAUL | Dir | — | $633.6K |
Transactions 24
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-23 16:35 | 2026-06-19 | AXGN | Axogen, Inc. | JOHNSON JOHN | Dir | M - OptEx | $0.00 | +14.2K | 14.2K | New | $0 |
| DT | 2026-06-05 18:17 | 2026-06-04 | XERS | Xeris Biopharma Holdings, Inc. | JOHNSON JOHN | Dir | S - Sale | $6.09 | -15.0K | 683.1K | -2% | -$91.4K |
| DT | 2026-06-05 18:17 | 2026-06-04 | XERS | Xeris Biopharma Holdings, Inc. | JOHNSON JOHN | Dir | A - Grant | $0.00 | +24.2K | 707.3K | +4% | $0 |
| 2026-05-26 18:12 | 2026-05-21 | VSTM | Verastem, Inc. | JOHNSON JOHN | Dir | A - Grant | $0.00 | +36.0K | 52.7K | +216% | $0 | |
| D | 2026-05-08 16:07 | 2026-05-07 | AXGN | Axogen, Inc. | JOHNSON JOHN | Dir | M - OptEx | $7.04 | +11.1K | 11.1K | New | +$77.8K |
| D | 2026-05-08 16:07 | 2026-05-07 | AXGN | Axogen, Inc. | JOHNSON JOHN | Dir | S - Sale+OE | $43.26 | -11.1K | 0 | -100% | -$478.0K |
| 2025-12-19 | 2025-12-19 | XERS | Xeris Biopharma Holdings, Inc. | JOHNSON JOHN | Dir | S - Sale | $7.22 | -135.4K | 698.1K | -16% | -$977.6K | |
| DM | 2025-12-10 | 2025-12-08+ | AXGN | Axogen, Inc. | JOHNSON JOHN | Dir | S - Sale+OE | $30.64 | -45.4K | 13.1K | -78% | -$1.39M |
| DM | 2025-12-10 | 2025-12-08+ | AXGN | Axogen, Inc. | JOHNSON JOHN | Dir | M - OptEx | $6.30 | +20.4K | 25.0K | +445% | +$128.7K |
| 2025-08-15 | 2025-08-13 | XERS | Xeris Biopharma Holdings, Inc. | JOHNSON JOHN | Dir | S - Sale | $7.32 | -107.5K | 833.5K | -11% | -$786.9K | |
| 2025-06-11 | 2025-06-09 | AXGN | Axogen, Inc. | JOHNSON JOHN | Dir | S - Sale | $10.61 | -4,073 | 24.9K | -14% | -$43.2K | |
| 2025-06-04 | 2025-06-04 | XERS | Xeris Biopharma Holdings, Inc. | JOHNSON JOHN | Dir | A - Grant | $0.00 | +50.0K | 941.0K | +6% | $0 | |
| D | 2025-05-27 | 2025-05-22 | VSTM | Verastem, Inc. | JOHNSON JOHN | Dir | A - Grant | $0.00 | +8,333 | 16.7K | +100% | $0 |
| D | 2024-09-04 | 2024-09-01 | AXGN | Axogen, Inc. | JOHNSON JOHN | Dir | M - OptEx | $0.00 | +11.9K | 29.0K | +70% | $0 |
| D | 2024-06-20 | 2024-06-18 | VSTM | Verastem, Inc. | JOHNSON JOHN | Dir | A - Grant | $0.00 | +8,333 | 8,333 | New | $0 |
| D | 2024-06-10 | 2024-06-06 | AXGN | Axogen, Inc. | JOHNSON JOHN | Dir | A - Grant | — | +10.7K | 17.1K | +165% | — |
| 2024-06-05 | 2024-06-05 | XERS | Xeris Biopharma Holdings, Inc. | JOHNSON JOHN | Dir | A - Grant | $0.00 | +50.0K | 891.0K | +6% | $0 | |
| 2024-04-01 | 2024-03-15 | XERS | Xeris Biopharma Holdings, Inc. | JOHNSON JOHN | Dir | J - Other | — | +89.6K | 841.0K | +12% | — | |
| D | 2024-03-18 | 2024-03-18 | XERS | Xeris Biopharma Holdings, Inc. | JOHNSON JOHN | Dir | M - OptEx | $1.99 | +215.6K | 751.4K | +40% | +$429.0K |
| 2023-06-07 | 2023-06-07 | XERS | Xeris Biopharma Holdings, Inc. | JOHNSON JOHN | Dir | A - Grant | $0.00 | +42.5K | 535.8K | +9% | $0 | |
| D | 2023-06-05 | 2023-06-01 | AXGN | Axogen, Inc. | JOHNSON JOHN | Dir | M - OptEx | $0.00 | +6,459 | 6,459 | New | $0 |
| D | 2022-06-09 | 2022-06-08 | XERS | Xeris Biopharma Holdings, Inc. | JOHNSON JOHN | Dir | A - Grant | $0.00 | +15.0K | 493.3K | +3% | $0 |
| DA | 2021-10-08 | 2021-10-05 | XERS | Xeris Biopharma Holdings, Inc. | JOHNSON JOHN | Dir | A - Grant | — | +478.3K | 478.3K | New | — |
| D | 2021-10-05 | 2021-10-05 | XERS | Xeris Biopharma Holdings, Inc. | JOHNSON JOHN | Dir | A - Grant | — | +478.3K | 478.3K | New | — |
Purchase Sale Sale after option exercise All abbreviations